The TEVAR Center

Filter Your Results




Cook Medical Issues Recall Correction to IFU for Zenith Alpha Thoracic Graft, Removing BTAI Indication

August 25, 2017 -- Cook Medical advised that on June 22, 2017, the company initiated a correction to the instructions for use (IFU) for its Zenith Alpha thoracic endovascular …

Acute Type A Aortic Dissection

Moderator: Ali Azizzadeh, MD, FACS
Panel: Benjamin Jackson, MD, FACS; Joseph Bavaria, MD, FACS; Kristofer M. Charlton-Ouw, MD, FACS; Anthony L. Estrera, MD, FACS; Michael Fischbein, MD, PhD; Michael D. Dake, MD; and Jason T. Lee, MD

August 2017—CASE PRESENTATION A 50-year-old man with no significant past medical history presents to the emergency department with chest pain radiating to his back. He also complains o…

National Inpatient Sample Used to Evaluate Impact of TEVAR on Ruptured TAA Management and Outcomes

August 9, 2017 -- Marc L. Schermerhorn, MD, led a study to assess national trends in the use of thoracic endovascular aortic repair (TEVAR) for the treatment of ruptured thora…

Gore’s TAG Conformable Thoracic Stent Graft With Active Control System Approved in Europe

July 13, 2017 -- Gore & Associates announced the first patient implant of its TAG conformable thoracic stent graft with Active Control System, which received European CE M…

Female Sex Studied as an Independent Predictor of Mortality After TEVAR for Intact Descending TAA

June 28, 2017 -- Findings from a retrospective review focusing on sex difference in thoracic endovascular aneurysm repairs (TEVARs) in the Society for Vascular Surgery Vascula…

FDA Clears Stroke2prevent's A-View Balloon Catheter for TEE

May 30, 2017 -- Stroke2prevent, a medical device company based in Zwolle, The Netherlands, announced that it has received US Food and Drug Administration 510(k) clearance for …

Results Published From the Pivotal Trial of Bolton Medical's Relay TEVAR Device

May 23, 2017 -- The initial and midterm results of the pivotal trial for the Relay thoracic stent graft (Bolton Medical) for thoracic endovascular aortic repair (TEVAR) of tho…

Bolton Medical Begins Phase 2 Trial for RelayPro to Treat Descending TAA

May 16, 2017 -- Bolton Medical announced that the first patient has been enrolled in the RelayPro US Food and Drug Administration (FDA) phase 2 clinical trial, which is design…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.